A licensed provider decides which option, dose, and schedule are appropriate based on your health history and goals
Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome
Ishrat T, Sayeed I, Atif F, Hua F, Stein DG
DPP-4 inhibitors may be preferred for: Patients unable or unwilling to use injectable therapies Elderly individuals where the lower hypoglycaemia risk is particularly valuable Those at high risk of hypoglycaemia from other medications Patients requiring modest glycaemic improvements Individuals where weight neutrality is acceptable or desired Important cautions and contraindications: Do not combine a GLP-1 receptor agonist with a DPP-4 inhibitor
Peters SAE, Huxley RR, Woodward M (2014) Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes
Can retatrutide replace diet and exercise